Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes

Clinical Cancer Research

Volumn 19, Issue 6, 2013, Pages 1353-1362

  Nguyen, David H ^a   Fredlund, Erik ^b   Zhao, Wei ^d   Perou, Charles M ^d   Balmain, Allan ^b   Mao, Jian Hua ^c   Barcellos Hoff, Mary Helen ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; ESTROGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOPHAGY; BIOINFORMATICS; BREAST CANCER; CANCER CLASSIFICATION; CANCER STEM CELL; CARCINOGENESIS; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; HUMAN; IONIZING RADIATION; MACROPHAGE; MICROANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID CANCER; TRP53 GENE; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; RADIATION, IONIZING; TRANSCRIPTOME; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875170634     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3554     Document Type: Article

References (48)

1. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005;7:21-32.
2. Shore RE, Hildreth N, Dvoretsky P, Andresen E, Moseson M, Pasternack B. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993;137: 1068-80.
3. Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst 1985;74:1177-84.
4. Tokunaga M, Land CE, Tokuoka S. Follow-up studies of breast cancer incidence among atomic bomb survivors. J Radiat Res (Tokyo) 1991;32(Suppl):201- 11.
5. Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125:214-22.
6. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 1986;77:689-96.
7. De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MWJ, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27:4239-46.
8. Perou CM, Sorlie T, Eisen MB, van de Rijn M, JeffreySS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-52.
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
10. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010;12:R68.
11. Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van't Veer L, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 2008;9:394.
12. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006;355:560-9.
13. Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, et al. Radiation effects on development of HER2-positive breast carcinomas. Clin Cancer Res 2007;13:46-51.
14. Wang SE, Narasanna A, Whitell CW,WuFY, Friedman DB, Arteaga CL. Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells 10.1074/jbc.M608499200. J Biol Chem 2007;282:5661-9.
15. Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, Stovall M, et al. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys 2010;76:540-7.
16. UNSCEAR. Sources and effects of ionizing radiation. NewYork: United Nations; 2006.
17. Tubiana M, Aurengo A, Averbeck D, Bonnin A, Le Guen B, Masse R, et al. Dose-effect relationships and estimation of the carcinogenic effect of low doses of ionizing radiation. Paris, France: Académie des Sciences- Académie Nationale de Médecine; 2005.
18. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer 2005;5: 867-75.
19. Little MP, Filipe JAN, Prise KM, Folkard M, Belyakov OV. A model for radiation-induced bystander effects, with allowance for spatial position and the effects of cell turnover. J Theor Biol 2005;232:329-38.
20. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008;8:465-72.
21. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000;60:1254-60.
22. Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, et al. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 2011;19:640-51.
23. Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, et al. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 2000;19: 1052-8.
24. Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, et al. Biological and genetic properties of the p53 null preneoplastic mammary epithelium. FASEB J 2002;16:881-3.
25. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 2003;19:185-93.
26. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
27. Parker JS, Mullins M, CheangMCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009;27:1160-7.
28. Ringnér M, Fredlund E, Häkkinen J, Borg Å, Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS ONE 2011;6:e17911.
29. Herschkowitz JI, Zhao W, Zhang M, Usary J, Murrow G, Edwards D, et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A 2011;109: 2778-83.
30. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76.
31. Liu Y, Hayes DN, Nobel A, Marron JS. Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 2008;103:1281-93.
32. Hadj-Hamou NS, Ugolin N, Ory C, Britzen-Laurent N, Sastre-Garau X, Chevillard S, et al. A transcriptome signature distinguished sporadic from post-radiotherapy radiation-induced sarcomas. Carcinogenesis 2011;32:929-34.
33. Ishida Y, Takabatake T, Kakinuma S, Doi K, Yamauchi K, Kaminishi M, et al. Genomic and gene expression signatures of radiation in medulloblastomas after low-dose irradiation in Ptch1 heterozygous mice. Carcinogenesis 2010;31:1694-701.
34. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, Tronko MD, et al. Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer 2005;92:1545-52.
35. Detours V, Delys L, Libert F, Weiss Solis D, Bogdanova T, Dumont JE, et al. Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 2007;97:818-25.
36. Delys L, Detours V, Franc B, Thomas G, Bogdanova T, Tronko M, et al. Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 2007;26:7894-903.
37. Huang E, Cheng SH, Dressman H, Pittman J, TsouMH,Horng CF, et al. Gene expression predictors of breast cancer outcomes. Lancet 2003;361:1590-6.
38. Brunet J-P, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci 2004;101:4164-9.
39. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100: 8418-23.
40. Moses H, Barcellos-Hoff MH. TGF-b biology in mammary development and breast cancer. Cold Spring Harbor Perspect Biol 2011;3: a003277.
41. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24+ and CD133+cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.
42. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang X-F, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010;28:17-28.
43. Hwang-VersluesWW,Kuo W-H, Chang P-H, Pan C-C, Wang H-H, Tsai S-T, et al. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE 2009;4: e8377.
44. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
45. Bruna A, Greenwood W, Le Quesne J, Teschendorff A, Miranda-Saavedra D, Rueda OM, et al. TGF-β induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat Commun 2012;3:1055.
46. Roman-Perez E, Casbas-Hernandez P, Pirone J, Rein J, Carey L, Lubet R, et al. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res 2012; 14:R51.
47. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008;14:518-27.
48. Lee S, Stewart S, Nagtegaal I, Luo J,WuY,Colditz G, et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 2012;72:4574-86.